Assessment of aortic elastic properties in patients with sarcoidosis

Blood Pressure

Volumn 21, Issue 5, 2012, Pages 286-292

  Ardic, Idris ^a   Yarlioglues, Mikail ^b   Dogdu, Orhan ^b   Buyukoglan, Hakan ^b   Kanbay, Asiye ^b   Akpek, Mahmut ^b   Bol, Canan ^b   Yuksel, Murat ^c   Akkaya, Emre ^a   Vuruskan, Ertan ^a   Kaya, Mehmet Gungor ^b  

^a Gaziantep 25 Aralik Hospital   (Turkey)

^b ERCIYES UNIVERSITY   (Turkey)

^c MALATYA STATE HOSPITAL   (Turkey)

Author keywords

Aortic elastic properties; Aortic wall stiffness; Echocardiography; Sarcoidosis

Indexed keywords

ADULT; AORTA; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DISEASE DURATION; ELASTICITY; FEMALE; HEART FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SARCOIDOSIS; TISSUE DOPPLER IMAGING; TRANSTHORACIC ECHOCARDIOGRAPHY; VEIN DIAMETER;

ADULT; AORTA; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; ELASTICITY; FEMALE; HUMANS; MALE; SARCOIDOSIS; VASCULAR STIFFNESS;

EID: 84866893769     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2012.656397     Document Type: Article

References (30)

1. Reich JM. What is sarcoidosis? Chest. 2003;124:367-171.
2. Habersberger J, Manins V, Taylor AJ. Cardiac sarcoidosis. Intern Med J. 2008;38:270-277.
3. Ardic I, Kaya MG, Yarlioglues M, Dogdu O, Buyukoglan H, Kalay N, et al. Impaired heart rate recovery index in patientswith sarcoidosis. Chest. 2011;139:60-68.
4. Eren M, Gorgulu S, Uslu N, Celik S, Dagdeviren B, Tezel T. Relation between aortic stiffness and left ventricular diastolicfunction in patients with hypertension, diabetes, or both. Heart. 2004;90:37-43.
5. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, GuizeL, et al. Aortic stiffness is an independent predictor of allcauseand cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236-1241.
6. Tavil Y, Ozt ü rk MA, Ureten K, Sen N, Kaya MG, Cemri M, et al. Assessment of aortic wall stiffness in patients with familialMediterranean fever. Joint Bone Spine. 2008;75:280-285.
7. Mäki-Petäjä KM, Booth AD, Hall FC, Wallace SM, Brown J, McEniery CM, et al. Ezetimibe and simvastatin reduceinflammation, disease activity, and aortic stiffness and improveendothelial function in rheumatoid arthritis. J Am Coll Cardiol2007;50:852-858.
8. Ardic I, Kaya MG, Yarlioglues M, Karadag Z, Dogan A, YildizH, et al. Impaired aortic elastic properties in normotensivepatients with psoriasis. Blood Press. 2010;19:351-358.
9. Dogdu O, Kaya MG, Yarlioglues M, Dogan A, Ardic I, ElcikD, et al. Impaired aortic elastic properties in patients withchronic graft-versus-host disease. Echocardiography 2011;28:1011-1018.
10. Moyssakis I, Gialafos E, Tentolouris N, Floudas CS, PapaioannouTG, Kostopoulos Ch, et al. Impaired aortic elasticproperties in patients with systemic sarcoidosis. Eur J ClinInvest. 2008;38:82-89.
11. Statement on sarcoidosis. Joint Statement of the AmericanThoracic Society (ATS), the European Respiratory Society(ERS) and the World Association of Sarcoidosis and OtherGranulomatous Disorders (WASOG) adopted by the ATSBoard of Directors and by the ERS Executive Committee, February1999. Am J Respir Crit Care Med. 1999;160:736-755.
12. Quinones MA, Otto CM, Stoddard M, Waggoner A, ZoghbiWA. Recommendations for quantification of Doppler echocardiography:A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of theAmerican Society of Echocardiography. J Am Soc Echocardiogr. 2002;15:167-184.
13. Stefanadis C, Stratos C, Boudoulas H, Kourouklis C, Toutouzas P. Distensibility of the ascending aorta: Comparisonof invasive and non-invasive techniques in healthy men and inmen with arterial disease. Eur Heart J. 1990;11:990-996.
14. Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, et al. ATS/ERS/WASOG statement onsarcoidosis. American Thoracic Society/European RespiratorySociety/World Association of Sarcoidosis and otherGranulomatous Disorders. Sarcoidosis Vasc Diffuse LungDis. 1999;16:149-173.
15. Sekiguchi M, Yazaki Y, Isobe M, Hiroe M. Cardiac sarcoidosis:Diagnostic, prognostic, and therapeutic considerations. Cardiovasc Drugs Ther. 1996;10:495-510.
16. Homsi M, Alsayed L, Safadi B, Mahenthiran J, Das MK. Fragmented QRS complexes on 12-lead ECG: A marker ofcardiac sarcoidosis as detected by gadolinium cardiac magneticresonance imaging. Ann Noninvasive Electrocardiol. 2009;14:319-326.
17. Uyarel H, Uslu N, Okmen E, Tartan Z, Kasikcioglu H, Dayi SU, et al. QT dispersion in sarcoidosis. Chest. 2005;128:2619-2625.
18. Hundley WG, Kitzman DW, Morgan TM, Hamilton CA, Darty SN, Stewart KP, et al. Cardiac cycle dependent changesin aortic area and distensibility are reduced in older patientswith isolated diastolic heart failure and correlate with exerciseintolerance. J Am Coll Cardiol. 2001;38:796-802.
19. O'Rourke MF, Nichols WW. Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolichypertension. Hypertension. 2005;45:652-658.
20. Ng WF, Fantin F, Ng C, Dockery F, Schiff R, Davies KA, et al. Takayasu ' s arteritis: A cause of prolonged arterial stiffness. Rheumatology (Oxford). 2006;45:741-745.
21. Tunc SE, Dogan A, Gedikli O, Arslan C, Sahin M. Assessmentof aortic stiffness and ventricular diastolic functions in patientswith Beh ç et ' s disease. Rheumatol Int. 2005;25:447-451.
22. TimárO, Soltész P, Szamosi S, Dér H, Szántó S, Szekanecz Z, et al. Increased arterial stiffness as the marker of vascularinvolvement in systemic sclerosis. J Rheumatol. 2008;35:1329-1333.
23. Edwards NC, Steeds RP, Stewart PM, Ferro CJ, Townend JN. Effect of spironolactone on left ventricular mass and aorticstiffness in early-stage chronic kidney disease: A randomizedcontrolled trial. J Am Coll Cardiol. 2009;54:505-512.
24. Maksimowicz-McKinnon K, Hoffman GS. Large-vessel vasculitis. Semin Respir Crit Care Med. 2004;25:569-579.
25. Fernandes SR, Singsen BH, Hoffman GS. Sarcoidosis andsystemic vasculitis. Semin Arthritis Rheum. 2000;30:33-46.
26. Baughman RP, Lower EE, Drent M. Inhibitors of tumor necrosisfactor (TNF) in sarcoidosis: Who, what, and how to usethem. Sarcoidosis Vasc Diffuse Lung Dis. 2008;25:76-89.
27. Fireman E, Gilburd D, Marmor S. Angiogenic cytokines ininduced sputum of patients with sarcoidosis. Respirology. 2009;14:117-123.
28. Mroz RM, Korniluk M, Stasiak-Barmuta A, Chyczewska E. Increased levels of interleukin-12 and interleukin-18 in bronchoalveolarlavage fluid of patients with pulmonary sarcoidosis. J Physiol Pharmacol. 2008;59:507-513.
29. Boots AW, Drent M, Swennen EL, Moonen HJ, Bast A, Haenen GR. Antioxidant status associated with inflammationin sarcoidosis: A potential role for antioxidants. Respir Med. 2009;103:364-372.
30. Katsuda S, Okada Y, Okada Y, Imai K, Nakanishi I. Matrixmetalloproteinase 9 (92-kd gelatinase/type IV collagenase) candegrade arterial elastin. Am J Pathol. 1994;144:1208-1218.